Mirador Therapeutics

San Diego, CA · Founded 2024 · Privately Held (backing)

Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. Mirador Therapeutics is based in San Diego, CA and was founded in 2024. It was valued at $1 billion at its early-stage round in Jan 2026, the last priced event on record. It has raised $735 million across 2 recorded rounds; the latest was a $333 million later-stage round in Feb 2024.

PMV mark · valuation
$1.0B
Oct 2026
Priced at
its early-stage round
Jan 2026
Total raised
$735.0M
Last round
Later Stage VC
Feb 2024

Who backs Mirador Therapeutics?

17 investors
InvestorType
Alexandria Venture InvestmentsOther
OrbiMedGrowth equity
ARCH Venture PartnersVenture capital
VenrockVenture capital
Blue Owl Capital—
Fidelity—
The Invus GroupPE / buyout
Moore Strategic VenturesVenture capital
Logos CapitalHedge fund
RTW InvestmentsHedge fund
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Mirador Therapeutics investors

17 investors are on record for Mirador Therapeutics, including Alexandria Venture Investments, OrbiMed, ARCH Venture Partners and Venrock. By type, the record holds 4 hedge funds and 3 venture capital firms. The later-stage round in Feb 2024 drew 31 investors.

Free account
More of Mirador Therapeutics with a free account
  • ·The complete investor list: 17 names
  • ·Watch Mirador Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Mirador Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View